Munck, A.; Enaud, R.; Languepin, J.; Remus, N.; Wizla, N.; Chedevergne, F.; Bui, S.; Arrouy, A.; Mittaine, M.; Quinn, M.;
et al. Impact of a Cystic Fibrosis Specific Multivitamin Formulation on Fat-Soluble Vitamin Status and Treatment Satisfaction in Young Children. Children 2025, 12, 1149.
https://doi.org/10.3390/children12091149
AMA Style
Munck A, Enaud R, Languepin J, Remus N, Wizla N, Chedevergne F, Bui S, Arrouy A, Mittaine M, Quinn M,
et al. Impact of a Cystic Fibrosis Specific Multivitamin Formulation on Fat-Soluble Vitamin Status and Treatment Satisfaction in Young Children. Children. 2025; 12(9):1149.
https://doi.org/10.3390/children12091149
Chicago/Turabian Style
Munck, Anne, Raphael Enaud, Jeanne Languepin, Natascha Remus, Nathalie Wizla, Frederique Chedevergne, Stephanie Bui, Amelie Arrouy, Marie Mittaine, Megan Quinn,
and et al. 2025. "Impact of a Cystic Fibrosis Specific Multivitamin Formulation on Fat-Soluble Vitamin Status and Treatment Satisfaction in Young Children" Children 12, no. 9: 1149.
https://doi.org/10.3390/children12091149
APA Style
Munck, A., Enaud, R., Languepin, J., Remus, N., Wizla, N., Chedevergne, F., Bui, S., Arrouy, A., Mittaine, M., Quinn, M., Wahlquist, A., & Sermet-Gaudelus, I.
(2025). Impact of a Cystic Fibrosis Specific Multivitamin Formulation on Fat-Soluble Vitamin Status and Treatment Satisfaction in Young Children. Children, 12(9), 1149.
https://doi.org/10.3390/children12091149